Clinical Trial Update: The Impact of Nicotinamide Mononucleotide Sustained-release Tablets on Immunosenescence and Metablism in Middle-aged and Elderly Individuals With Metabolic Disorders. [NA]

View source ↗

Summary

Clinical trial investigating the effects of nicotinamide mononucleotide sustained-release tablets on immunosenescence and metabolism in middle-aged and older ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Disorders

Drugs mentioned

• Nicotinamide Mononucleotide Sustained-release Tablets (nicotinamide mononucleotide)

Snippet

Sponsor: Qing Su | Conditions: Immunosenescence, Metabolism | NA | Status: RECRUITING